Clinical Research Directory

The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

Sponsor: National Nutrition and Food Technology Institute

Summary

In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks. IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.

Official title: The Effects of Low FODMAP Diets Accompanied With and Without Bromelain Supplement on Quality of Life, Disease Activity Index and Inflammation in Patients With Ulcerative Colitis With and Without Primary Sclerosis Cholangitis

Key Details

Conditions

Interventions

Locations (1)